The purpose of The P.O.W.E.R. study:
What is the time commitment for the P.O.W.E.R. study?
- The study will take about five months to complete with five to six clinic visits and three phone calls
What is tildacerfont?
Is tildacerfont safe?
Tildacerfont is generally well-tolerated in healthy volunteers and in people with rare endocrine conditions.
- Generally well-tolerated across a diverse group of people
- Generally well-tolerated at doses under evaluation
- No reported drug-related serious adverse events (SAEs)
Finding the support you need
The Spruce Patient Engagement Team
Living with a rare endocrine condition can be a complex journey at times that you don’t have to navigate alone. The Spruce Patient Engagement Team offers personalized support and access to resources for people living with androgen- mediated polycystic ovary syndrome (PCOS).
Spruce Patient Engagement Liaisons (PELs) work closely with individuals, families, advocacy groups, and healthcare providers to better understand the needs of these communities. PELs provide education and resources related to these conditions and serve as contact for local advocacy and support groups.
Connecting with organizations and local support groups can help people understand more about their condition and meet others in the PCOS community.
These groups and websites are neither owned nor controlled by Spruce Bio. Spruce does not endorse and is not responsible for the content or services they provide..
The purpose of the Spruce Patient Education Liaison (PEL) is to provide education to patients, their families, and caregivers. PELs are employees of Spruce Bio. They are not acting as healthcare providers and are not part of your healthcare team. PELs do not provide medical care or advice. All diagnosis and treatment decisions should be made by you and your healthcare team.
“I am proud to serve as a trusted resource and
advocate for members of the PCOS community.”
– Mara VanAndel
References: 1. Additional entry criteria applies; 2. Sarafoglou K, et al. J Clin Endocrinol Metab. 2021;106(11):e4666-e4679. doi:10.1210/clinem/dgab438;
SPRUCE BIOSCIENCES, INC.
611 Gateway Blvd
Suite 740
South San Francisco, CA 94080 USA